1-9 of 9
Davine Hofste op Bruinink
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MAF Translocations Are Enriched in NDMM Patients with Elevated Levels of Circulating Tumor Cells Suggesting a Genetic Basis for Aggressive Disease Course

Cathelijne Fokkema, Madelon M.E. de Jong, Sabrin Tahri, Davine Hofste Op Bruinink, Zoltan Kellermayer, Chelsea den Hollander, Michael Vermeulen, Natalie Papazian, Mark van Duin, Remco Hoogenboezem, Michiel J.W. Wevers, Vincent H.J. van der Velden, Mathijs A. Sanders, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9917–9918.
https://doi.org/10.1182/blood-2022-166162
Published: 2022
Journal Articles

Combining Plasma Cell Leukemia-like Status with the Second Revision of the International Staging System Improves Risk Classification

Davine Hofste op Bruinink, Rowan Kuiper, Mark van Duin, Tom Cupedo, Vincent H.J. van der Velden, Remco Hoogenboezem, Bronno van der Holt, Berna Beverloo, Erik T. Valent, Michael Vermeulen, Mattia D'Agostino, Francesca Gay, Annemiek Broijl, Herve Avet-Loiseau, Nikhil C Munshi, Pellegrino Musto, Philippe Moreau, Sonja Zweegman, Niels W.C.J. van de Donk, Pieter Sonneveld
Journal: Blood
Blood (2022) 140 (Supplement 1): 1566–1567.
https://doi.org/10.1182/blood-2022-170249
Published: 2022
Journal Articles

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste op Bruinink, MD MSc, Mark van Duin, PhD, Meral Beksac, MD, Christoph Driessen, MD, Heinz Ludwig, MD, Michael Vermeulen, BSc, Rowan Kuiper, MSc, Martin H van Vliet, PhD, Bronno van der Holt, PhD, Roman Hajek, MD PhD, Hans Erik Johnsen, MD Professor, Meletios A Dimopoulos, MD, Antonio Palumbo, MD, Michele Cavo, MD, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3186.
https://doi.org/10.1182/blood-2018-99-119873
Published: 2018
Journal Articles

Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse

Kristine Misund, PhD, Davine Hofste Op Bruinink, MD, Eivind Coward, PhD, Remco Hoogenboezem, MSc, Even H Rustad, MD, Eivind Hovig, PhD, Anders Sundan, PhD, Ola Myklebost, PhD, Pieter Sonneveld, MD PhD, Anders Waage, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3157.
https://doi.org/10.1182/blood-2018-99-113553
Published: 2018
Journal Articles

The Level of Circulating Myeloma Cells at Diagnosis Correlates with a Plasma Cell Leukemia-like Phenotype of the Corresponding Myeloma Cells in Bone Marrow

Davine Hofste Op Bruinink, MD, Vincent van der Velden, PhD, Mark van Duin, PhD, Berna Beverloo, PhD, Jeroen te Marvelde, BSc, Chelsea den Hollander, BSc, Rowan Kuiper, MSc, Michel Delforge, MDPhD, Martin H van Vliet, PhD, Niels WCJ van de Donk, MDPhD, Hervé Avet-Loiseau, MDPhD, Philippe Moreau, MDPhD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4368.
https://doi.org/10.1182/blood.V130.Suppl_1.4368.4368
Published: 2017
Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD
Journal: Blood
Blood (2016) 128 (22): 2072.
https://doi.org/10.1182/blood.V128.22.2072.2072
Published: 2016
Journal Articles

Multiple Myeloma with a Deletion of Chromosome 17p: TP53 Mutations Are Highly Prevalent and Negatively Affect Prognosis

Davine Hofste op Bruinink, MD MSc, Hoogenboezem Remco, MSc, Mathijs A. Sanders, PhD, Christopher P Wardell, PhD, Cody Ashby, PhD, Eric M.J. Bindels, PhD, Claudia Erpelinck-Verschueren, BSc, Paulette van Strien, BSc, Jasper Koenders, BSc, François G. Kavelaars, BSc, Jie He, PhD, Mark Bailey, MSc, Tariq I Mughal, MD FRCP, Kristine Misund, PhD, Berna Beverloo, PhD, Bronno van der Holt, PhD, Ivo Touw, PhD, Anders Waage, MDPhD, Hervé Avet-Loiseau, MD PhD, Graham H Jackson, MD PhD, Gareth J Morgan, MD PhD, Brian A Walker, PhD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2016) 128 (22): 3271.
https://doi.org/10.1182/blood.V128.22.3271.3271
Published: 2016
Journal Articles

Targeted Genomic Mutation Panel (M 3 P) Results from 504 Multiple Myeloma (MM) Patients

K Martin Kortuem, Esteban Braggio, Pieter Sonneveld, MD PhD, Laura Ann Bruins, Santiago Barrio, Davine Hofste op Bruinink, Mark vanDuin, Elias Karl Mai, MD, Nur Hanafiah, Hartmut Goldschmidt, MD, Sanchin Pathangey, Yanira Ruiz Heredia, Inmaculada Rapado, Beatriz Sanchez-Vega, Stefan Knop, Leo Rasche, Christian Langer, Miriam Kull, Lars Bullinger, Monika Engelhardt, Joaquin Martinez-Lopez, Hermann Einsele, Marc S. Raab, A. Keith Stewart
Journal: Blood
Blood (2015) 126 (23): 1795.
https://doi.org/10.1182/blood.V126.23.1795.1795
Published: 2015
Journal Articles

M3P Sequencing Panel Identifies TP53 Mutational Status As a Prognostic Factor in Chemotherapy-Naive Multiple Myeloma

Davine Hofste op Bruinink, MD MSc, K. Martin Kortüm, MD, Mark van Duin, PhD, Mathijs A. Sanders, PhD, Remco Hoogenboezem, MSc, Michael Vermeulen, BSc, Laura Bruins, Jonathan Ahmann, Annemiek Broijl, MD PhD, Sonja Zweegman, MD PhD, Esteban Braggio, PhD, Bronno van der Holt, PhD, A. Keith Stewart, MD PhD, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2984.
https://doi.org/10.1182/blood.V126.23.2984.2984
Published: 2015